These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 27185909)
1. LAP-like process as an immune mechanism downstream of IFN-γ in control of the human malaria Plasmodium vivax liver stage. Boonhok R; Rachaphaew N; Duangmanee A; Chobson P; Pattaradilokrat S; Utaisincharoen P; Sattabongkot J; Ponpuak M Proc Natl Acad Sci U S A; 2016 Jun; 113(25):E3519-28. PubMed ID: 27185909 [TBL] [Abstract][Full Text] [Related]
2. Long-term live imaging reveals cytosolic immune responses of host hepatocytes against Plasmodium infection and parasite escape mechanisms. Prado M; Eickel N; De Niz M; Heitmann A; Agop-Nersesian C; Wacker R; Schmuckli-Maurer J; Caldelari R; Janse CJ; Khan SM; May J; Meyer CG; Heussler VT Autophagy; 2015; 11(9):1561-79. PubMed ID: 26208778 [TBL] [Abstract][Full Text] [Related]
3. LC3B labeling of the parasitophorous vacuole membrane of Plasmodium berghei liver stage parasites depends on the V-ATPase and ATG16L1. Bindschedler A; Schmuckli-Maurer J; Buchser S; Fischer TD; Wacker R; Davalan T; Brunner J; Heussler VT Mol Microbiol; 2024 Jun; 121(6):1095-1111. PubMed ID: 38574236 [TBL] [Abstract][Full Text] [Related]
13. IFN-γ protects hepatocytes against Plasmodium vivax infection via LAP-like degradation of sporozoites. Lelliott PM; Coban C Proc Natl Acad Sci U S A; 2016 Jun; 113(25):6813-5. PubMed ID: 27286823 [No Abstract] [Full Text] [Related]
14. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea. Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890 [TBL] [Abstract][Full Text] [Related]
15. Immune responses to Plasmodium vivax pre-erythrocytic stage antigens in naturally exposed Duffy-negative humans: a potential model for identification of liver-stage antigens. Wang R; Arevalo-Herrera M; Gardner MJ; Bonelo A; Carlton JM; Gomez A; Vera O; Soto L; Vergara J; Bidwell SL; Domingo A; Fraser CM; Herrera S Eur J Immunol; 2005 Jun; 35(6):1859-68. PubMed ID: 15864779 [TBL] [Abstract][Full Text] [Related]
17. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Sattabongkot J; Yimamnuaychoke N; Leelaudomlipi S; Rasameesoraj M; Jenwithisuk R; Coleman RE; Udomsangpetch R; Cui L; Brewer TG Am J Trop Med Hyg; 2006 May; 74(5):708-15. PubMed ID: 16687667 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure. Changrob S; Han JH; Ha KS; Park WS; Hong SH; Chootong P; Han ET Malar J; 2017 Aug; 16(1):348. PubMed ID: 28830553 [TBL] [Abstract][Full Text] [Related]
20. Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection. Cheng Y; Wang B; Changrob S; Han JH; Sattabongkot J; Ha KS; Chootong P; Lu F; Cao J; Nyunt MH; Park WS; Hong SH; Lim CS; Tsuboi T; Han ET Malar J; 2017 May; 16(1):211. PubMed ID: 28532483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]